As 2021 draws to a close, the Journal of Drugs in Dermatology ends the year on a high note! Featuring a strong line up of editorials, original articles, and case reports, the December issue of the JDD includes topics ranging from new treatments for hyperpigmentation, tumescent anesthesia, HS, cosmeceuticals, lower extremity reconstruction, laser hair and identity in transgender men, and everything in between. Straight from the Editor’s desk, we share this month’s issue highlights:
Topical Stabilized Cysteamine as a New Treatment for Hyperpigmentation Disorders: Melasma, Post-Inflammatory Hyperpigmentation, and Lentigines provides evidence of a recent breakthrough.
A timeline highlighting major developments is the focus of Tumescent Anesthesia: A Brief History Regarding the Evolution of Tumescent Solution.
A Patient-Centered Guide to Hidradenitis Suppurativa Flare Prevention offers options to manage and treat this chronic, incurable skin disease.
Evaluation of Picosecond 755-nm Alexandrite Laser With a Diffractive Lens Array on Pore Size Reduction examines results from the trial of participants who underwent treatment using this device.
In Unna Boot With Keystone Advancement Flap Leads to Excellent Outcomes for Lower Extremity Reconstruction, the authors discovered that this combination treatment was successful.
Clinical Study to Evaluate the Efficacy and Tolerability of Cosmeceuticals Targeting the Dermal Epidermal Junction covers the results that tested this dual-product regimen.
In Topical S. aureus-Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis, the authors assess the efficacy and tolerance of a cream containing this technology.
In Safe Use of Adapalene 0.1 % Gel in a non-Prescription Environment, authors conclude that this drug’s OTC version is both safe and effective.
Results from the study performed on 20 volunteers were deemed successful in The Efficacy and Safety of a Novel Protective Complex Combined With 50% Glycolic Acid Peel: A Double-Blinded, Split Face, Controlled Study.
Chromate-Induced Allergic Contact Dermatitis Treated With Dupilumab focuses on the effectiveness of this drug on one patient whose occupation (cement mason) caused severe symptoms.
Delayed Metastatic Polypoid Nodular Melanoma Diagnosis During COVID-19 Pandemic, Successful Treatment With Surgery and Nivolumab establishes the effectiveness of this combined method on a 74-year-old patient.
Proliferating Pilar Tumor: Two Cases and a Review of the Literature presents symptoms in two patients, and additionally includes a table summarizing relevant literature from 2007 to 2020.
Authors aim to prove that injections are an effective option to reduce symptoms in Severe Ulcerative Perniosis Treated With Abobotulium Toxin.
Disseminate and Recurrent Infundibulofolliculitis: An Under-Recognized Yet Treatable Entity summarizes the limited options available for DRIF, the rare skin condition with only a handful of documented cases.
Body Hair and Identity in Transgender Men: A Cross-Sectional Survey provides statistics on the results collected from this study.
Did you enjoy this article? Find more JDD Issue Highlights here.
